Modifiable risk factors for permanent pacemaker after transcatheter aortic valve implantation: CONDUCT registry
暂无分享,去创建一个
T. Geisler | J. Baan | N. Nielsen | P. Bramlage | M. Droppa | T. Rudolph | J. Baranowski | Jana Kurucova | L. Hack | V. Hachaturyan
[1] B. Prendergast,et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. , 2021, European heart journal.
[2] D. Fischman,et al. Predictors of Permanent Pacemaker Implantation in Patients Undergoing Transcatheter Aortic Valve Replacement ‐ A Systematic Review and Meta‐Analysis , 2021, Journal of the American Heart Association.
[3] W. Aronow,et al. Predictors of permanent pacemaker insertion after TAVR: A systematic review and updated meta‐analysis , 2021, Journal of cardiovascular electrophysiology.
[4] R. Fan,et al. Effects of COPD on in‐hospital outcomes of transcatheter aortic valve implantation: Results from the National Inpatient Sample database , 2020, Clinical cardiology.
[5] R. Arora,et al. Two-year outcomes from the PARTNER 3 trial: where do we stand? , 2020, Current opinion in cardiology.
[6] W. Rottbauer,et al. Risk factors for permanent pacemaker implantation in patients receiving a balloon-expandable transcatheter aortic valve prosthesis , 2020, Heart and Vessels.
[7] L. Fauchier,et al. Pacemaker Implantation After Balloon‐ or Self‐Expandable Transcatheter Aortic Valve Replacement in Patients With Aortic Stenosis , 2020, Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease.
[8] E. Agricola,et al. Impact of Left Ventricular Outflow Tract Calcification on Pacemaker Implantation After Transcatheter Aortic Valve Implantation With Second-Generation Devices. , 2020, The Journal of invasive cardiology.
[9] Adnan Kastrati,et al. Evaluación multicéntrica del sobredimensionamiento de la prótesis transcatéter SAPIEN 3. Impacto en el fallo del dispositivo y nuevos implantes de marcapasos , 2019, Revista Española de Cardiología.
[10] C. Hengstenberg,et al. Multicenter Evaluation of Prosthesis Oversizing of the SAPIEN 3 Transcatheter Heart Valve. Impact on Device Failure and New Pacemaker Implantations. , 2019, Revista espanola de cardiologia.
[11] W. Rottbauer,et al. New generation devices for transfemoral transcatheter aortic valve replacement are superior compared with last generation devices with respect to VARC-2 outcome , 2018, Cardiovascular Intervention and Therapeutics.
[12] Jeroen J. Bax,et al. Pacemaker implantation rate after transcatheter aortic valve implantation with early and new-generation devices: a systematic review , 2018, European heart journal.
[13] T. Folliguet,et al. Incidence, indications and predicting factors of permanent pacemaker implantation after transcatheter aortic valve implantation: A retrospective study. , 2017, Archives of cardiovascular diseases.
[14] D. Berman,et al. A Highly Predictive Risk Model for Pacemaker Implantation After TAVR. , 2017, JACC. Cardiovascular imaging.
[15] W. Rottbauer,et al. Predictors for permanent pacemaker implantation in patients undergoing transfemoral aortic valve implantation with the Edwards Sapien 3 valve , 2017, Clinical Research in Cardiology.
[16] C. Macaya,et al. Transcatheter versus surgical aortic valve replacement in moderate and high-risk patients: a meta-analysis , 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[17] S. Rosenkranz,et al. Predictors of Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement With the SAPIEN 3. , 2016, JACC. Cardiovascular interventions.
[18] M. Laule,et al. Optimized Implantation Height of the Edwards SAPIEN 3 Valve to Minimize Pacemaker Implantation After TAVI. , 2016, Journal of interventional cardiology.
[19] H. Baumgartner,et al. Changes in the Pacemaker Rate After Transition From Edwards SAPIEN XT to SAPIEN 3 Transcatheter Aortic Valve Implantation: The Critical Role of Valve Implantation Height. , 2016, JACC. Cardiovascular interventions.
[20] M. Mack,et al. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. , 2016, The New England journal of medicine.
[21] Mao Chen,et al. VALVULAR AND STRUCTURAL HEART DISEASES Original Studies The Relationship Between Chronic Obstructive Pulmonary Disease and Transcatheter Aortic Valve Implantation — A Systematic Review and Meta-Analysis , 2016 .
[22] C. Hengstenberg,et al. Predictors of Permanent Pacemaker Implantations and New-Onset Conduction Abnormalities With the SAPIEN 3 Balloon-Expandable Transcatheter Heart Valve. , 2016, JACC. Cardiovascular interventions.
[23] U. Steinseifer,et al. Calcium distribution patterns of the aortic valve as a risk factor for the need of permanent pacemaker implantation after transcatheter aortic valve implantation. , 2016, European heart journal cardiovascular Imaging.
[24] G. Gerosa,et al. Unravelling the (arte)fact of increased pacemaker rate with the Edwards SAPIEN 3 valve. , 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[25] Peter Jüni,et al. Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta-analysis. , 2014, Journal of the American College of Cardiology.
[26] T. Helmberger,et al. MSCT guided sizing of the Edwards Sapien XT TAVI device: impact of different degrees of oversizing on clinical outcome. , 2013, International journal of cardiology.
[27] P. Leprince,et al. Prognostic Implications of Pulmonary Hypertension in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation: Study From the FRANCE 2 Registry , 2013, Circulation. Cardiovascular interventions.
[28] Jennifer Taylor,et al. ESC/EACTS Guidelines on the management of valvular heart disease. , 2012, European heart journal.
[29] D. Wood,et al. Edwards SAPIEN 3 valve. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[30] Stuart J Pocock,et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. , 2011, The New England journal of medicine.
[31] M. Mack,et al. Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry. , 2015, JACC. Cardiovascular interventions.